Sign up to save your podcasts
Or
Share Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease
CME credits: 0.50
Valid until: 25-12-2020
Claim your CME credit at https://reachmd.com/programs/cme/clinical-exchanges-optimizing-management-of-nontuberculous-mycobacteria-lung-disease/11060/
The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors underscore the importance of specialty referral and shared decision making in the successful management of NTM-LD, as Dr. Anne O’Donnell and her patient Brinkley exemplify.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.50
Valid until: 25-12-2020
Claim your CME credit at https://reachmd.com/programs/cme/clinical-exchanges-optimizing-management-of-nontuberculous-mycobacteria-lung-disease/11060/
The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors underscore the importance of specialty referral and shared decision making in the successful management of NTM-LD, as Dr. Anne O’Donnell and her patient Brinkley exemplify.